EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Anti-sarcopenic effect of leucine-enriched branched-chain amino acid supplementation among elderly chronic kidney disease patients: a double-blinded randomized controlled trial

Neti Sunsandee, Paramat Thimachai, Bancha Satirapoj, Ouppatham Supasyndh

International Urology and Nephrology · 2025

DOI: 10.1007/s11255-025-04560-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Urology and Nephrology, 2025. Verfasst von Neti Sunsandee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand. Hauptthemen laut MEDLINE: Leucine, Renal Insufficiency, Chronic, Dietary Supplements, Sarcopenia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Department of Medicine, Phramongkutkloa Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Leucine, a branched-chain amino acid (BCAA), is an effective nutritional strategy to enhance skeletal muscle mass in aging populations. This study aimed to evaluate the effects of oral leucine-enriched BCAA supplementation on muscle mass, muscle synthesis biomarkers, and physical performance in elderly patients with chronic kidney disease (CKD). METHODS: A randomized controlled trial was conducted among CKD patients aged over 65 years. The participants were randomly assigned to receive either oral mixed BCAA supplementation (60% leucine, 4.5 g/day; 20% valine, 1.5 g/day; 20% isoleucine, 1.5 g/day) (N = 29) or a placebo (N = 26) for 12 weeks. Muscle mass, serum insulin-like growth factor 1 (IGF-1), and myostatin levels were measured at baseline and after 12 weeks. A 3-day food record was reviewed by a dietitian, and functional capacity was assessed using handgrip and 6-min walk tests. RESULTS: Fifty-five patients (mean age 75.4 ± 5.2 years) were enrolled. Daily protein and calorie intake were comparable between groups. At study conclusion, lean muscle mass significantly increased in the leucine group compared to placebo (0.4 kg [95% CI 0.1-0.7] vs. - 0.2 kg [95% CI - 0.6-0.2], P = 0.010). A significant difference in the percentage change in muscle mass was also observed (1.0 ± 1.8% vs. - 0.5 ± 2.6%, P = 0.014). No significant differences were found in muscle strength, serum myostatin, IGF-1, or adverse events. CONCLUSIONS: Leucine-enriched BCAA supplementation for 12 weeks significantly increased muscle mass but did not impact biomarkers of muscle activity or functional capacity in elderly CKD patients. CLINICAL TRIAL REGISTRATION: TCTR20200314003.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeucineRenal Insufficiency, ChronicDietary SupplementsSarcopeniaAmino Acids, Branched-ChainHumansDouble-Blind MethodMaleAgedFemaleAged, 80 and overMuscle, SkeletalInsulin-Like Growth Factor I

Stichwörter der Autor:innen

Body compositionChronic kidney diseaseLeucineMuscle wastingSarcopenia

Substanzen

LeucineAmino Acids, Branched-ChainInsulin-Like Growth Factor I

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
  • Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand. satirapoj@yahoo.com.
  • Biomedical Research Center, Faculty of Medicine, Kasetsart University, Bangkok, Thailand.

Förderung

  • Department of Medicine, Phramongkutkloa Hospital

Zitieren

APA

Sunsandee, N., Thimachai, P., Satirapoj, B., & Supasyndh, O. (2025). Anti-sarcopenic effect of leucine-enriched branched-chain amino acid supplementation among elderly chronic kidney disease patients: a double-blinded randomized controlled trial. International Urology and Nephrology. https://doi.org/10.1007/s11255-025-04560-9

Vancouver

Sunsandee N, Thimachai P, Satirapoj B, Supasyndh O. Anti-sarcopenic effect of leucine-enriched branched-chain amino acid supplementation among elderly chronic kidney disease patients: a double-blinded randomized controlled trial. International Urology and Nephrology. 2025. doi:10.1007/s11255-025-04560-9

BibTeX
@article{Sunsandee2025,
  author = {Sunsandee, Neti and Thimachai, Paramat and Satirapoj, Bancha and Supasyndh, Ouppatham},
  title = {Anti-sarcopenic effect of leucine-enriched branched-chain amino acid supplementation among elderly chronic kidney disease patients: a double-blinded randomized controlled trial},
  journal = {International Urology and Nephrology},
  year = {2025},
  doi = {10.1007/s11255-025-04560-9}
}
Kostenlos starten →